Grafa News and Videos — Page 461

Fate Therapeutics (NASDAQ:FATE) received FDA clearance for its investigational new drug application regarding the FT839 candidate.

TOMI Environmental Solutions (NASDAQ:TOMZ) reported a 124% year-over-year increase in preliminary second-quarter revenue to $2.3 million.

Teva (NYSE:TEVA) signed a global licensing agreement with Polpharma Biologics for a proposed multiple sclerosis biosimilar.

Steel Partners Holdings offered to acquire all outstanding shares of InMode (NASDAQ:INMD) for $16.75 each.

Meta Platforms (NASDAQ:META) will begin manufacturing its in-house Iris artificial intelligence processor in September.

Seven Hills Realty Trust (NASDAQ:SEVN) announced a regular quarterly cash distribution of $0.28 per common share.

Delcath Systems (NASDAQ:DCTH) dosed the first patient in a 90-person Phase 2 clinical trial evaluating a cancer therapy.

Northern Technologies (NASDAQ:NTIC) reported third-quarter fiscal 2026 sales of $24.2 million.

Byrna Technologies (NASDAQ:BYRN) reported a steep contraction in its financial metrics for the second quarter of 2026, navigating a heavy product restructuring phase marked by deep asset write-downs and an overhaul of its manufacturing footprint.

PepsiCo (NASDAQ:PEP) delivered a dependable set of operational results for the second quarter of 2026, driven by a sharp rebound in underlying sales volumes across its international portfolios and an evolving product mix.